139527-58-5

Upstream product

• 119944-89-7 (2S)-N-(acryloyl)bornane-10,2-sultam 
• 139527-57-4 3-[(R)-2-Hydroxy-1-(2-methoxy-6-methyl-phenyl)-ethyl]-6-methyl-3,6-diaza-bicyclo[3.1.0]hexane-2,4-dione 
• 151858-73-0 (4S,5R,2'R)-3-(2-azido-2-(2-methoxy-6-methylphenyl)acetyl)-4-methyl-5-phenyl-1,3-oxazolidin-2-one 
• 151858-72-9 (4S,5R)-3-(2-(2-methoxy-6-methylphenyl)acetyl)-4-methyl-5-phenyl-1,3-oxazolidin-2-one 
• 151858-79-6 (R)-1-<2-(acetyloxy)-1-(2-methoxy-6-methylphenyl)ethyl>-1H-pyrrole-2,5-dione 
• 151858-78-5 -4-<<2-hydroxy 1-(2-methoxy-6-methylphenyl)ethyl>amino>-4-oxo-2-butenoic acid 
• 151858-82-1 (R)-1-<2-hydroxy-1-(2-methoxy-6-methylphenyl)ethyl>-1H-pyrrole-2,5-dione 
• 151858-74-1 (2R)-2-azido-2-(2-methoxy-6-methylphenyl)ethanol 
• 151858-75-2 (2R)-2-amino-2-(2-methoxy-6-methylphenyl)ethyl alcohol 
• 151858-71-8 (2-methoxy-6-methylphenyl)acetic acid 

Downstream Products

• 139527-59-6 <3aR-<1<1S^*,3(R^*),5R^*,6R^*>,3aα,6α,7aβ>>-1-<<3-<2-(methoxymethoxy)-1-(2-methoxy-6-methylphenyl)ethyl>-8-methyl-2,4-dioxo-3,8-diazabicyclo<3.2.1>oct-6-yl>carbonyl>hexahydro-8,8-dimethyl-2,2-dioxo-3H-3a,6-methano-2,1-benzisothiazole 
• 139527-61-0 (2-{(R)-1-[(1R,5S,6R)-6-((1R,5S,7S)-10,10-Dimethyl-3,3-dioxo-3λ⁶-thia-4-aza-tricyclo[5.2.1.0^1,5]decane-4-carbonyl)-8-methyl-2,4-dioxo-3,8-diaza-bicyclo[3.2.1]oct-3-yl]-2-methoxymethoxy-ethyl}-3-methoxy-benzyl)-triphenyl-phosphonium; bromide 
• 139527-60-9 (1R,5S,6R)-3-[(R)-1-(2-Bromomethyl-6-methoxy-phenyl)-2-methoxymethoxy-ethyl]-6-((1R,5S,7S)-10,10-dimethyl-3,3-dioxo-3λ⁶-thia-4-aza-tricyclo[5.2.1.0^1,5]decane-4-carbonyl)-8-methyl-3,8-diaza-bicyclo[3.2.1]octane-2,4-dione 
• 96251-59-1 4-cyano-6-hydroxymethyl-3,12-imino-7-methoxy-13-methyl-1,2,3,4,6,11,11a,12-octahydroazepino<1,2-b>isoquinoline-1-carboxylic acid 
• 84573-33-1 (-)-quinocarcin 
• 139527-59-6 (1R,5S,6R)-6-((1R,5S,7S)-10,10-Dimethyl-3,3-dioxo-3λ⁶-thia-4-aza-tricyclo[5.2.1.0^1,5]decane-4-carbonyl)-3-[(R)-2-methoxymethoxy-1-(2-methoxy-6-methyl-phenyl)-ethyl]-8-methyl-3,8-diaza-bicyclo[3.2.1]octane-2,4-dione 

Relevant academic research and scientific papers

The asymmetric synthesis of (-)-quinocarcin via a 1,3-dipolar cycloadditive strategy

Details of the asymmetric synthesis and complete structure elucidation of (-)-quinocarcin (1), an antitumor antibiotic that inhibits DNA (and in some systems RNA) synthesis, are reported. Key steps in the synthesis include the use of an auxiliary-controll